Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause

Stefan D. Anker

, Department of Cardiology (CVK), , Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, , Berlin, , Germany,

, Charité Universitätsmedizin Berlin, , Berlin, , Germany,

, Institute of Heart Diseases, , Wrocław Medical University, , Wrocław, , Poland,

View original article

JOURNAL OF THE AMERICAN HEART ASSOCIATION

Like

分享书签

0 0 0 0 0 0 0

More from this channel

Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause

留言 (0)